These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333 [TBL] [Abstract][Full Text] [Related]
29. Statins and Their Effect on PCSK9-Impact and Clinical Relevance. Taylor BA; Thompson PD Curr Atheroscler Rep; 2016 Aug; 18(8):46. PubMed ID: 27315084 [TBL] [Abstract][Full Text] [Related]
30. Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE Gu L; Gong Y; Zhao C; Wang Y; Tian Q; Lei G; Liang Y; Zhao W; Tan S Molecules; 2019 Nov; 24(22):. PubMed ID: 31731717 [TBL] [Abstract][Full Text] [Related]
31. The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function. Di Costanzo A; Indolfi C; Sorrentino S; Esposito G; Spaccarotella CAM Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511498 [TBL] [Abstract][Full Text] [Related]
32. Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy. Pradhan AD; Aday AW; Rose LM; Ridker PM Circulation; 2018 Jul; 138(2):141-149. PubMed ID: 29716940 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9. Ferri N; Ruscica M; Lupo MG; Vicenzi M; Sirtori CR; Corsini A Pharmacol Res; 2022 Oct; 184():106439. PubMed ID: 36100012 [TBL] [Abstract][Full Text] [Related]
34. Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. Bergeron N; Phan BA; Ding Y; Fong A; Krauss RM Circulation; 2015 Oct; 132(17):1648-66. PubMed ID: 26503748 [TBL] [Abstract][Full Text] [Related]
35. Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance. Koskinas K; Wilhelm M; Windecker S Swiss Med Wkly; 2016; 146():w14333. PubMed ID: 27400448 [TBL] [Abstract][Full Text] [Related]
36. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. Urban D; Pöss J; Böhm M; Laufs U J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703 [TBL] [Abstract][Full Text] [Related]
37. Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? Sbrana F; Dal Pino B; Bigazzi F; Ripoli A; Passino C; Gabutti A; Pasanisi EM; Petersen C; Valleggi A; Todiere G; Barison A; Giannoni A; Panchetti L; Becherini F; Pianelli M; Luciani R; Sampietro T Eur J Prev Cardiol; 2017 Sep; 24(14):1528-1531. PubMed ID: 28555526 [TBL] [Abstract][Full Text] [Related]
38. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. Dong B; Wu M; Li H; Kraemer FB; Adeli K; Seidah NG; Park SW; Liu J J Lipid Res; 2010 Jun; 51(6):1486-95. PubMed ID: 20048381 [TBL] [Abstract][Full Text] [Related]
39. Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition with Bococizumab on Lipoprotein Particles in Hypercholesterolemic Subjects. Wan H; Gumbiner B; Joh T; Riel T; Udata C; Forgues P; Garzone PD Clin Ther; 2017 Nov; 39(11):2243-2259.e5. PubMed ID: 29037448 [TBL] [Abstract][Full Text] [Related]
40. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy. Joseph L; Robinson JG Prog Cardiovasc Dis; 2015; 58(1):19-31. PubMed ID: 25936907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]